Next Article in Journal
FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway
Next Article in Special Issue
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
Previous Article in Journal
Thyroid Disease Prediction Using Selective Features and Machine Learning Techniques
Previous Article in Special Issue
The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
 
 
Article

Article Versions Notes

Cancers 2022, 14(16), 3916; https://doi.org/10.3390/cancers14163916
Action Date Notes Link
article xml file uploaded 13 August 2022 11:26 CEST Original file -
article xml uploaded. 13 August 2022 11:26 CEST Update https://www.mdpi.com/2072-6694/14/16/3916/xml
article pdf uploaded. 13 August 2022 11:26 CEST Version of Record https://www.mdpi.com/2072-6694/14/16/3916/pdf
article html file updated 13 August 2022 11:28 CEST Original file -
article supplementary file uploaded. 15 August 2022 09:13 CEST - https://www.mdpi.com/2072-6694/14/16/3916#supplementary
article html file updated 15 August 2022 09:14 CEST Update https://www.mdpi.com/2072-6694/14/16/3916/html
Back to TopTop